![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 401/04 | |
A61K 31/506 | |||
C07D 403/04 | |||
C07D 239/26 | |||
A61P 25/00 |
(11) | Number of the document | 3022189 |
(13) | Kind of document | T |
(96) | European patent application number | 14742326.3 |
Date of filing the European patent application | 2014-07-17 | |
(97) | Date of publication of the European application | 2016-05-25 |
(45) | Date of publication and mention of the grant of the patent | 2018-09-26 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/GB2014/052184 |
Date | 2014-07-17 |
(87) | Number | WO 2015/008073 |
Date | 2015-01-22 |
(30) | Number | Date | Country code |
201312800 | 2013-07-17 | GB |
(72) |
CHRISTOPHER, John, Andrew, GB
CONGREVE, Miles, Stuart, GB
AVES, Sarah, Joanne, GB
TEHAN, Benjamin, Gerald, GB
|
(73) |
Heptares Therapeutics Limited,
BioPark Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AX,
GB
|
(54) | 4-(3-CYANOPHENYL)-6-PYRIDINYLPYRIMIDINE MGLU5 MODULATORS |
4-(3-CYANOPHENYL)-6-PYRIDINYLPYRIMIDINE MGLU5 MODULATORS |